col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Journal of Allergy and Clinical Immunology
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―15 Immunological memory to SARS-CoV-2 in convalescent COVID-19 patients at one-year post-infection Hongyan Hou, Yandi Zhang, Guoxing Tang, Ying Luo, Wei Liu, Chang Cheng, et al. (+7)
2 [GO] 2021―Sep―14 Occupational Health Disparities: The Pandemic as Prism and Prod Emily Brigham, Drew Harris, Christopher Carlsten, Carrie A. Redlich
3 [GO] 2021―Sep―08 Immunologic resilience and COVID-19 survival advantage Grace C. Lee, Marcos I. Restrepo, Nathan Harper, Muthu Saravanan Manoharan, Alisha M. Smith, Justin A. Meunier, et al. (+34)
4 [GO] 2021―Sep―04 Antibody responses to the SARS-CoV-2 vaccine in individuals with various Inborn Errors of Immunity Ottavia M. Delmonte, Jenna R.E. Bergerson, Peter D. Burbelo, Jessica R. Durkee-Shock, Kerry Dobbs, Marita Bosticardo, et al. (+22)
5 [GO] 2021―Jul―31 Abnormality in the NK cell population is prolonged in severe COVID-19 patients Galam Leem, Shinhye Cheon, Hoyoung Lee, Seong Jin Choi, Seongju Jeong, Eui-Soon Kim, et al. (+5)
6 [GO] 2021―Jul―24 Maternal COVID-19 disease, vaccination safety in pregnancy, and evidence of protective immunity Amelie Pham, David M. Aronoff, Jennifer L. Thompson
7 [GO] 2021―Jul―17 SARS-CoV-2-infected primary human airway epithelia illustrate mucus hypersecretion Wilfried Posch, Cornelia Lass-Flörl, Doris Wilflingseder
8 [GO] 2021―Jul―15 Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination Mary M. Tomayko, William Damsky, Ramie Fathy, Devon E. McMahon, Noel Turner, Monica N. Valentin, et al. (+4)
9 [GO] 2021―Jun―15 COVID-19 risk and outcomes in adult asthmatics treated with biologics or systemic corticosteroids : nationwide real-world evidence Yochai Adir, Marc Humbert, Walid Saliba
10 [GO] 2021―Jun―07 Chemokines and Eicosanoids Fuel the Hyperinflammation Within the Lungs of Patients with Severe COVID-19 Younes Zaid, Étienne Doré, Isabelle Dubuc, Anne-Sophie Archambault, Olivier Flamand, Michel Laviolette, et al. (+3)
11 [GO] 2021―Jun―01 Immunogenicity of Pfizer-BioNTech COVID-19 Vaccine in Patients with Inborn Errors of Immunity. David Hagin, Tal Freund, Michal Navon, Tami Halperin, Dikla Adir, Rotem Marom, et al. (+4)
12 [GO] 2021―Apr―22 Distinct cytokine profiles associated with COVID-19 severity and mortality Karim Dorgham, Paul Quentric, Mehmet Gökkaya, Stéphane Marot, Christophe Parizot, Delphine Sauce, et al. (+19)
13 [GO] 2021―Apr―21 Potential Mechanisms of Anaphylaxis to COVID-19 mRNA Vaccines Kimberly A. Risma, Kathryn M. Edwards, Donna S. Hummell, Frederic F. Little, Allison E. Norton, Amy Stallings, et al. (+2)
14 [GO] 2021―Apr―21 C5aR inhibition of non-immune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2-infected primary human airway epithelia Wilfried Posch, Jonathan Vosper, Asma Noureen, Viktoria Zaderer, Christina Witting, Giulia Bertacchi, et al. (+7)
15 [GO] 2021―Apr―17 Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis Andri Lemarquis, Tessa Campbell, Maribel Aranda-Guillén, Viktoria Hennings, Petter Brodin, Olle Kämpe, et al. (+8)
16 [GO] 2021―Mar―14 Asthma and viruses (a focus on rhinoviruses and SARS-CoV-2) Yorissa Padayachee, Tasnim Shahridan Faiez, Aran Singanayagam, Patrick Mallia, Sebastian Lennox Johnston
17 [GO] 2021―Mar―01 Interleukin-6-based mortality prediction model for COVID-19: validation and update in multicentre and second wave cohorts Alberto Utrero-Rico, Javier Ruiz-Hornillos, Cecilia González-Cuadrado, Claudia Geraldine Rita, Berta Almoguera, Pablo Minguez, et al. (+11)
18 [GO] 2021―Feb―09 SARS-CoV-2 Infection and Viral Load are Associated with the Upper Respiratory Tract Microbiome Christian Rosas-Salazar, Kyle S. Kimura, Meghan H. Shilts, Britton A. Strickland, Michael H. Freeman, Bronson C. Wessinger, et al. (+5)
19 [GO] 2021―Feb―06 Efficacy of early anti-inflammatory treatment with high doses IV Anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia Emanuele Pontali, Stefano Volpi, Alessio Signori, Giancarlo Antonucci, Marco Castellaneta, Davide Buzzi, et al. (+17)
20 [GO] 2021―Feb―01 Rapid Adoption of Video Visits and Return-to-Clinic Procedures to Maintain Access to Allergy/Immunology Care Delivery During COVID-19 Lulu Tsao, Stephanie Anne Villanueva Ferraris, David Pines, Eugene Choo, Michele Pham, Monica Tang, et al. (+5)
21 [GO] 2021―Feb―01 Clinical conditions of patients with chronic urticaria during the pandemic caused by the 2019 Novel Coronavirus Disease (COVID-19) Paula Argolo, Grazielly Pereira, G.F. Pereira, Jorge Kalil, Antonio Motta, Rosana Agondi
22 [GO] 2021―Feb―01 Attitudes Among Faculty Members and Trainees About the Effects of Telemedicine on Clinical Education During COVID-19 Patrick Gleeson, Di Sun, Jennifer Heimall, Olajumoke Fadugba
23 [GO] 2021―Feb―01 Phase 1 Randomized Placebo-Controlled Study in Healthy Adult Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate - A Potential Treatment for COVID-19 Ohad Bentur, Richard Hutt, Donna Brassil, Per Bäckman, Igor Gonda, Homer Boushey, et al. (+3)
24 [GO] 2021―Feb―01 Associations of Asthma, COPD and Medication History with the Risk of Severe COVID-19 Brian Huang, Zhanghua Chen, Margo Sidell, Sandrah Eckel, Mayra Martinez, Fred Lurmann, et al. (+3)
25 [GO] 2021―Feb―01 Loss of sense of smells associated with sour taste is a possible diagnostic marker for COVID-19 Mohammad Asad, Esha Sehanobish, Valerie Fong, Meaghan O'Neill, Viraj Patel, Danielle Bottalico, et al. (+13)
26 [GO] 2021―Feb―01 Intravenous Immunoglobulin for Treatment of Severe Coronavirus Disease 19 (COVID-19) - A Literature Overview Syed Rizvi, Huub Kreuwel
27 [GO] 2021―Feb―01 Five-month Outcomes for Asthmatics with COVID-19 and Associations with Atopy and Inhaled Corticosteroids Use Katharine Foster, Donyea Moore, Emilio Jauregui, Aame Andy-Nweye, Mahboobeh Mahdavinia
28 [GO] 2021―Feb―01 COVID-19 and Common Variable Immunodeficiency Marina Kaminski, Gabriela Yoshimoto, Luiza Silva, Ana Garcia, Natasha Ferraroni
29 [GO] 2021―Feb―01 Point-of-care assays can detect COVID-19 antibodies via serum or whole blood Charles Schuler, James Baldwin, James Baker
30 [GO] 2021―Feb―01 Blood Dendritic Cells, Monocytes and Myeloid-derived Suppressor Cells in Patients with COVID-19 Associated Pneumonia Andrei Hancharou, Alena Rynda, Yana Minich, Natalia Antonevich, Oxana Timohina, Alena Halavach, et al. (+4)
31 [GO] 2021―Feb―01 Undiagnosed, familial cold auto-inflammatory syndrome (FCAS) masquerading as COVID-19 cytokine storm Dilawar Khokhar, James Baker
32 [GO] 2021―Feb―01 Immune Predictors of Death versus Survival in COVID-19 ICU Pneumonia Patients on Mechanical Ventilators Natalia Antonevich, Andrei Hancharou, Alena Rynda, Marina Dotsenko, Eduard Dotsenko, Alena Halavach, et al. (+4)
33 [GO] 2021―Feb―01 COVID-19 Impact on Participant Engagement with a School-centered Asthma Navigator Program Melanie Gleason, Arthur McFarlane, Mfonobong Udoko, Elizabeth Konon, Stanley Szefler
34 [GO] 2021―Feb―01 Risk Factors for Mortality from COVID-19 in a New York Inner city Epicenter Mariam Majzoub, Rauno Joks
35 [GO] 2021―Feb―01 A Case of Mild COVID-19 in a Teenager with Common Variable Immunodeficiency and Granulomatous Interstitial Lung Disease on Replacement Immunoglobulin and Infliximab Yatyng Chang, Daniel Urschel, Vivian Hernandez-Trujillo, Jose Calderon
36 [GO] 2021―Feb―01 Analysis Of COVID-19 In Adult Asthmatic Outpatients Maria Somoza Alvarez, Ana MarÃa Prieto-Moreno Pfeifer, Isabel Torres Rojas, Maria Desamparados Cervera, Diana Perez-Alzate, Maria Vazquez de La Torre, et al. (+5)
37 [GO] 2021―Feb―01 Multi-system Inflammatory syndrome in Children (MIS-C): an evolving presentation of COVID-19 in the pediatric population: A Florida State experience and our management approach Farida Karim, Miry Makebish, Pallavi Agarwal, Callah Antonetti
38 [GO] 2021―Feb―01 DiGeorge Syndrome and COVID-19 in Two Pediatric Patients Eilaf Fallatah, Yatyng Chang, Jose Calderon, Vivian Hernandez- Trujillo
39 [GO] 2021―Feb―01 A Survey of Respiratory Symptoms Reported in Patients Following Hospitalization with COVID-19 Infection Eevar B. Rossavik, Zain Iftikhar, Iftikhar Hussain
40 [GO] 2021―Feb―01 Asthma as a predictor of more severe outcomes in COVID-19 infection Lauren Eggert, Shu Cao, Ziyuan He, Gopal Krishna Dhondalay, Shirley Jiang, William Collins, et al. (+3)
41 [GO] 2021―Feb―01 Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season. Ijaz Ogeer, Wardha. Wardha, Vaidehi Bhatt, Vince Wu, Saajida Hosein, Tyler Seto, Tenzin Gyaltsen
42 [GO] 2021―Feb―01 The impact of COVID-19 on patients with food protein-induced enterocolitis syndrome (FPIES) and their caregivers. Brit Trogen, Hope Jin, Antonella Cianferoni, Fallon Schultz, Amity Chavez, Anna Nowak-Wegrzyn
43 [GO] 2021―Feb―01 Management of a Immunotherapy Unit During the COVID-19 Outbreak: Building a Resilient Health Care System. Inmaculada Sanchez-Machin, Ruperto Gonzalez Perez, Paloma Poza Guedes, Cristina Alava Cruz, Elena Mederos Luis, Victor Matheu
44 [GO] 2021―Feb―01 COVID-19 pandemia: Atopy and prospective analysis of the clinical evolution of patients infected with the SARS-CoV-2 virus Débora S. Guterres, Ana Carolina Dos Santos, Marina de Almeida Prado Meireles Laubi, Marina Laubi, Roselene Lourenço, Marcus Vinícius, et al. (+5)
45 [GO] 2021―Feb―01 An Institutional Survey of Patient Satisfaction with Telemedicine Services in Pediatric Allergy During the COVID-19 Pandemic Kasey Lanier, Merin Kuruvilla, Jennifer Shih
46 [GO] 2021―Feb―01 Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic Lois Kang, Maya Goldman, Anny Uyehara, Michael Goldman
47 [GO] 2021―Feb―01 Continuing Peanut Oral Immunotherapy via Telemedicine During the COVID-19 Pandemic Anna Schoonover, Anny Uyehara, Michael Goldman
48 [GO] 2021―Feb―01 Assessment of Anxiety, Depression and Resilience in Food-Allergic Adolescents and Primary Caregivers During the COVID-19 Pandemic Ashton Rogers, Emily Seminara, Caitlan Murphy, Diana Munoz-Mendoza, Amika Sood, Ellen Manegold, et al. (+3)
49 [GO] 2021―Feb―01 Utilizing the ASTHMAXcel PRO Mobile Platform to Conduct a Virtual Cohort Study During the COVID-19 Pandemic Emine Cosar, Savneet Kaur, Anjani Singh, Obumneme Njeze, Brian Hsia, Sunit Jariwala
50 [GO] 2021―Feb―01 Remote Data Collection Through the ASTHMAXcel Mobile Application, and Lessons Learned During the COVID-19 Pandemic Brian Hsia, Anjani Singh, Obumneme Njeze, Emine Cosar, Savneet Kaur, Sunit Jariwala
51 [GO] 2021―Feb―01 Changes in food spending among food allergic families following the COVID-19 pandemic Michael Golding, Catherine Lemoine-Courcelles, Elissa Abrams, Moshe Ben-Shoshan, Edmond Chan, Derek Chu, et al. (+5)
52 [GO] 2021―Feb―01 Increased adherence to controller medication maintained during the COVID-19 pandemic Benjamin Theye, Leanne Kaye, Jared Nagano, Rahul Gondalia, Meredith Barrett, David Stempel
53 [GO] 2021―Feb―01 Allergy & Immunology Involvement on Multidisciplinary Treatment Team During COVID-19 Pandemic Veronica Azmy, Kelsey Kaman, Christina Price
54 [GO] 2021―Feb―01 COVID-19 Pandemic and Telehealth: allergy patient perspectives in an urban, academic medical center Darshil Patel, Andrea Pappalardo, Vanessa Harmon, Mary Pasquinelli, Julia Trosman, Christine Weldon, Sharmilee Nyenhuis
55 [GO] 2021―Feb―01 Patient's perceived quality and satisfaction of Teleconsultation Services in an Allergy Department during COVID-19 pandemic era Aida Bermejo-Becerro, Filip Skrabski, Esperanza Pérez-Pallisé, Sandra Rodríguez-Hermida, José Manuel Zubeldia, Alberto Alvarez-Perea
56 [GO] 2021―Feb―01 Implications of the COVID-19 Pandemic on Asthma Control and Socioeconomic Factors in Inner-City Cohort: A Rapid Online Cross-Sectional Survey Thanaporn Ratchataswan, Christina Yee, Caroline Mortelliti, Amparito Cunningham, Lisa Bartnikas, Wanda Phipatanakul
57 [GO] 2021―Feb―01 Consequences of the COVID-19 pandemic on grocery shopping habits of food allergic families Michael Golding, Cathérine Lemoine-Courcelles, Elissa Abrams, Moshe Ben-Shoshan, Philippe Begin, Edmond Chan, et al. (+6)
58 [GO] 2021―Feb―01 Understanding the impact of the COVID-19 pandemic on physical and mental health Shu Cao, Hena Din, Christopher Warren, Jessica Fitzpatrick, Tina Hernandez-Boussard, Manisha Desai, et al. (+2)
59 [GO] 2021―Feb―01 Impact of the COVID-19 pandemic on physical and mental health among individuals with primary immunodeficiency: results of a nationwide survey Deepti Deshpande, Christopher Scalchunes, Jordan Orange, Joshua Milner
60 [GO] 2021―Feb―01 Immunodeficiency during COVID-19 pandemic: analysis of a 243 patients' cohort followed at a Brazilian tertiary hospital Laís Cunha, Priscila Franco, Bruna Gehlen, Mariana Fernandes, Alex Prado, Grazielly Pereira, et al. (+6)
61 [GO] 2021―Feb―01 Asthma care during the COVID-19 pandemic: Differences in attitudes and expectations between physicians and patients Nonie Arora, Desmond Lowe, Nadeen Sarsour, Hannah Jaffee, Sanaz Eftekhari, Laurie Carpenter, et al. (+2)
62 [GO] 2021―Feb―01 Characterization of T cell, B cell and Natural Killer Cell Subsets in COVID-19 Patients Alena Rynda, Andrei Hancharou, Natalia Antonevich, Oxana Timohina, Yana Minich, Alena Halavach, et al. (+4)
63 [GO] 2021―Feb―01 SARS-CoV-2 entry factors are expressed in nasal, ocular, and oral tissues: implications for COVID-19 prophylaxes/therapeutics Ivan Lee, Tsuguhisa Nakayama, Sizun Jiang, Yury Goltsev, Christian Schürch, Bokai Zhu, et al. (+7)
64 [GO] 2021―Feb―01 Risk Factors Associated With COVID-19 Related Anosmia And Ageusia Esha Sehanobish, Mali Barbi, Valerie Fong, Meryl Kravitz, Cynthia Matsumura, Denise Tejera, et al. (+14)
65 [GO] 2021―Feb―01 Going Beyond Virus Biology: COVID-19's Impact on the Mental Health of Pediatric Populations in an Allergy Community Jason Ohayon, Tenzin Gyaltsen, Tyler Seto, Vaidehi Bhatt, Wardha. Wardha, Ijaz Ogeer, et al. (+2)
66 [GO] 2021―Feb―01 COVID-19, severe asthma and biologicals targeting type 2 inflammation: results in a third-level hospital in Madrid, Spain. Alicia Domínguez Estirado, Gabriela Zambrano Ibarra, Filip Skrabski, Francisco Javier De Castro Martínez, Julia De Pedro, Maria Pilar Sanz Sanz, et al. (+2)
67 [GO] 2021―Feb―01 COVID-19 severity in asthma patients: A multi-center matched cohort study Lacey Robinson, Liqin Wang, Xiaoquing Fu, Zachary Wallace, Aidan Long, Yuqing Zhang, et al. (+2)
68 [GO] 2021―Feb―01 COVID-19 Severity in Hospitalized Pediatric Patients with Atopic Disease Dylan Timberlake, Rebecca Scherzer, Benjamin Prince, Mitchell Grayson
69 [GO] 2021―Feb―01 Recent Mumps-Measles-Rubella Vaccination Probably Reduces COVID-19 Severity: A Proposed Strategy For Close-Contacts Of Patients Desiree Larenas - Linnemann, Fernanda Rodríguez Monroy
70 [GO] 2021―Feb―01 Intensive Infection Control at a Canadian Tertiary Allergy and Clinical Immunology Clinic during COVID-19 to Provide Crucial Services Jodi Valois, Hoang Pham, Derek Lanoue, Tim Olynych, William Yang
71 [GO] 2021―Feb―01 SARS-CoV-2 full length spike protein for COVID-19 vaccine development and diagnostic testing Crystal Richardson, Mayuresh Abhyankar, Jillian Bracaglia, Sayeh Agah, Zachary Schuhmacher, Bryan Smith, et al. (+4)
72 [GO] 2021―Feb―01 A COVID-19 vaccine success? patients perception of Covid vaccination program Wardha. Wardha, Vaidehi Bhatt, Tyler Seto, Vince Wu
73 [GO] 2021―Feb―01 COVID-19-Associated Hospitalization and Outcomes in Patients with Asthma: A Systematic Review and Meta-analysis Andrea Sitek, Justine Ade, Mitchell M. Pitlick, Sergio Chiarella, Rohit Divekar, Vivek Iyer, et al. (+2)
74 [GO] 2021―Feb―01 Implementation of Virtual Training Visits During the Coronavirus Pandemic: a Nursing Perspective Linda Trotto, Christopher Vanname, Timothy Kingas
75 [GO] 2021―Feb―01 Does Point-Of-Care SARS-CoV-2 Antibody Testing Have Similar Sensitivity and Specificity To High Complexity Serology? Kelly O'Shea, Charles Schuler, Jesse Chen, Carmen Gherasim, Donald Giacherio, James Baldwin, James Baker
76 [GO] 2021―Feb―01 An effective approach for recombinant production of select SARS-CoV-2 proteins in Escherichia coli Sayeh Agah, Catherine Thorpe, Martin Chapman, Sabina Wuenschmann
77 [GO] 2021―Feb―01 Quantitative Measurement of IgG to SARS-CoV-2 Proteins Using the Phadia ImmunoCAP 250 Behnam Keshavarz, Joseph Wiencek, Lindsay Bazydlo, Matthew Straesser, Lisa Workman, Thomas Platts-Mills, Jeffrey Wilson
78 [GO] 2021―Feb―01 Cellular and humoral immunity in patients infected with the SARS-CoV-2 virus at general hospital Valéria Brandão, Thaís T. Saito, Débora S. Guterres, Grasiele Lima, Sara Tencarte, Ana Carolina Dos Santos, et al. (+7)
79 [GO] 2021―Feb―01 Clinical Characteristics of SARS-CoV2 Infected and Exposed Patients at a Tertiary Care Allergy/Immunology Program in Florida Mary Ann Miranda, Joseph Dasso, Maryssa Ellison, Jessica Trotter, Priyanka Timothy, Maria Chitty-Lopez, et al. (+9)
80 [GO] 2021―Feb―01 Outcomes of SARS-CoV2 infection in STAT3 and PGM3 Deficiency Muhammad Khalid, Amanda Urban, Dirk Darnell, Alexandra Freeman
81 [GO] 2021―Feb―01 Prolonged Maintenance Interval Of Allergen Subcutaneous Immunotherapy during COVID19 pandemic Jaspreet Dhami, Vivian Wang, Mohamed Eloustaz, Joseph Yusin
82 [GO] 2021―Feb―01 How To Care For Errors of Innate Immunity (EII) Patients During The Pandemic In a Developing Country Without Telemedicine? Raissa Roque, Fernanda Vaz, Rafael Saldanha, Caroline Ferreira, Nathalia Vital, Pedro Bubach, et al. (+6)
83 [GO] 2021―Jan―22 Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies Matthew T. Patrick, Haihan Zhang, Rachael Wasikowski, Errol P. Prens, Stephan Weidinger, Johann E. Gudjonsson, et al. (+3)
84 [GO] 2021―Jan―19 mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis Tiago Azenha Rama, André Moreira, Mariana Castells
85 [GO] 2020―Dec―17 Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2 Terrie S. Ahn, Brandon Han, Paul Krogstad, Chantana Bun, Lisa A. Kohn, Maria I. Garcia-Lloret, et al. (+2)
86 [GO] 2020―Dec―16 COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience. Adrian M. Shields, Siobhan O. Burns, Sinisa Savic, Alex G. Richter
87 [GO] 2020―Dec―03 Marked changes in innate immunity associated with a mild course of COVID-19 in identical twins with athymia and absent circulating T cells Argentina Colmenero Velázquez, Gloria Esteso, Teresa del Rosal, Ane Calvo Apalategui, Hugh Reyburn, Eduardo López-Granados
88 [GO] 2020―Nov―20 Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19 Carlo Cervia, Jakob Nilsson, Yves Zurbuchen, Alan Valaperti, Jens Schreiner, Aline Wolfensberger, et al. (+19)
89 [GO] 2020―Nov―19 Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: an observational cohort study Giorgio Bozzi, Davide Mangioni, Francesca Minoia, Stefano Aliberti, Giacomo Grasselli, Laura Barbetta, et al. (+20)
90 [GO] 2020―Nov―05 Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: a Northern Italy experience Gisondi Paolo, Piaserico Stefano, Naldi Luigi, Dapavo Paolo, Conti Andrea, Malagoli Piergiorgio, et al. (+17)
91 [GO] 2020―Nov―05 The United States’ Reckoning with Racism during the COVID-19 pandemic: What can we learn and do as Allergist-Immunologists? Lakiea S. Wright, Margee Louisias, Wanda Phipatanakul
92 [GO] 2020―Oct―28 Pathways for Bradykinin Formation and Interrelationship with Complement as a Cause of Edematous Lung in COVID-19 Patients Allen P. Kaplan, Berhane Ghebrehiwet
93 [GO] 2020―Oct―26 Eosinophilic pulmonary vasculitis as a manifestation of the hyperinflammatory phase of COVID-19 Eva Luecke, Andreas Jeron, Andrea Kroeger, Dunja Bruder, Sabine Stegemann-Koniszewski, Doerthe Jechorek, et al. (+7)
94 [GO] 2020―Oct―23 Compartmental immunophenotyping in COVID-19 ARDS: A case series Andreas Ronit, Ronan M.G. Berg, Jakob T. Bay, Anna K. Haugaard, Magnus G. Ahlström, Kristoffer S. Burgdorf, et al. (+7)
95 [GO] 2020―Oct―16 COVID-19 Associated Multisystem Inflammatory Syndrome in Children (MIS-C): a novel disease that mimics Toxic Shock Syndrome. The superantigen hypothesis Magali Noval Rivas, Rebecca A. Porritt, Mary Hongying Cheng, Ivet Bahar, Moshe Arditi
96 [GO] 2020―Oct―16 Factors associated with adverse COVID-19 outcomes in patients with psoriasis - insights from a global registry-based study Satveer K. Mahil, Nick Dand, Kayleigh J. Mason, Zenas ZN. Yiu, Teresa Tsakok, Freya Meynell, et al. (+30)
97 [GO] 2020―Oct―15 Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon Lydia J. Finney, Nicholas Glanville, Hugo Farne, Julia Aniscenko, Peter Fenwick, Samuel V. Kemp, et al. (+8)
98 [GO] 2020―Oct―09 COVID-19 risk stratification algorithms based on sTREM-1 and IL-6 in emergency department Mathias Van Singer, Thomas Brahier, Michelle Ngai, Julie Wright, Andrea M. Weckman, Clara Erice, et al. (+4)
99 [GO] 2020―Sep―30 IL-6 serum levels predict severity and response to Tocilizumab in COVID-19: an observational study José María Galván-Román, Sebastián C. Rodríguez-García, Emilia Roy-Vallejo, Ana Marcos-Jiménez, Santiago Sánchez-Alonso, Carlos Fernández-Díaz, et al. (+33)
100 [GO] 2020―Sep―30 Severe SARS-CoV-2 Disease In The Context Of A NFκB2 Loss-Of-Function Pathogenic Variant Roshini S. Abraham, Joanna M. Marshall, Hye Sun Kuehn, Cesar M. Rueda, Amber Gibbs, Will Guider, et al. (+13)
101 [GO] 2020―Sep―29 COVID-19 and upper respiratory tract: Collecting swab specimens from patients inhaling corticosteroids Eftychios Siniorakis, Spyridon Arvanitakis, Titika Sfakianaki, Antonios Katsianis, Athanasios Sinaniotis, Veneta Papagiannopoulou
102 [GO] 2020―Sep―29 Asthma-associated risk for COVID-19 development Chrysanthi Skevaki, Antonina Karsonova, Alexander Karaulov, Min Xie, Harald Renz
103 [GO] 2020―Sep―29 Pulmonary edema in COVID-19: Explained by bradykinin? Suzanne Zwaveling, Roy Gerth van Wijk, Faiz Karim
104 [GO] 2020―Sep―24 Coronavirus Disease 2019 in patients with inborn errors of immunity: an international study Isabelle Meyts, Giorgia Bucciol, Isabella Quinti, Bénédicte Neven, Alain Fischer, Elena Seoane, et al. (+49)
105 [GO] 2020―Sep―21 Elevated plasma sTIM-3 levels in severe Covid-19 patients Thor Ueland, Lars Heggelund, Andreas Lind, Aleksander R. Holten, Kristian Tonby, Annika E. Michelsen, et al. (+20)
106 [GO] 2020―Sep―17 Whether the timing of patient randomization interferes with the assessment of the efficacy of ruxolitinib for severe COVID-19 Hailan Li, Huaping Liu
107 [GO] 2020―Sep―10 Characterization of the Cytokine Storm Reflects Hyperinflammatory Endothelial Dysfunction in COVID-19 Jonathan T. Sims, Venkatesh Krishnan, Ching-Yun Chang, Sarah M. Engle, Giacomo Casalini, George H. Rodgers, et al. (+11)
108 [GO] 2020―Sep―04 The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection Ana Copaescu, Olivia Smibert, Andrew Gibson, Elizabeth J. Phillips, Jason A. Trubiano
109 [GO] 2020―Sep―04 The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
110 [GO] 2020―Aug―15 Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study Jee Myung Yang, Hyun Yong Koh, Sung Yong Moon, In Kyung Yoo, Eun Kyo Ha, Seulgi You, et al. (+3)
111 [GO] 2020―Aug―14 COVID-19: Start with the nose Brian Lipworth, Rory Chan, Chris RuiWen Kuo
112 [GO] 2020―Aug―06 Asthma Among Hospitalized Patients with COVID-19 and Related Outcomes Stephanie Lovinsky-Desir, Deepti R. Deshpande, Aliva De, Laurie Murray, Jeanette A. Stingone, Angela Chan, et al. (+5)
113 [GO] 2020―Jul―29 Risk factors for hospitalization, intensive care and mortality among patients with asthma and COVID-19 Liqin Wang, Dinah Foer, David W. Bates, Joshua A. Boyce, Li Zhou
114 [GO] 2020―Jul―23 Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities Zita-Rose Manjaly Thomas, Anne Leuppi-Taegtmeyer, Dagmar Jamiolkowski, Esther Steveling-Klein, Felicitas Bellutti-Enders, Kathrin Scherer Hofmeier, Karin Hartmann
115 [GO] 2020―Jul―22 Interleukin-6-based mortality risk model for hospitalised COVID-19 patients Laguna-Goya Rocio, Utrero-Rico Alberto, Talayero Paloma, Lasa-Lazaro Maria, Ramirez-Fernandez Angel, Naranjo Laura, et al. (+11)
116 [GO] 2020―Jul―03 Nucleic Acid Approaches to Antibody-based Therapeutics for COVID-19: A Perspective Elizabeth Parzych, David B. Weiner
117 [GO] 2020―Jul―02 Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective Koa Hosoki, Abhijit Chakraborty, Sanjiv Sur
118 [GO] 2020―Jun―22 Asthmatic patients in COVID-19 outbreak: Few cases despite many cases Marco Caminati, Carlo Lombardi, Claudio Micheletto, Elena Roca, Barbara Bigni, Fabiana Furci, et al. (+3)
119 [GO] 2020―Jun―17 Risk and Management of Patients with Mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) Pandemic: Expert Opinions * Peter Valent, Cem Akin, Patrizia Bonadonna, Knut Brockow, Marek Niedoszytko, Boguslaw Nedoszytko, et al. (+20)
120 [GO] 2020―Jun―15 Prevalence and characterization of asthma in hospitalized and non-hospitalized patients with COVID-19 Krishan D. Chhiba, Gayatri B. Patel, Thanh Huyen T. Vu, Michael M. Chen, Amina Guo, Elizabeth Kudlaty, et al. (+13)
121 [GO] 2020―Jun―13 Molecular pharmacology of ciclesonide against SARS-CoV-2 Hirokazu Kimura, Hiromu Kurusu, Mitsuru Sada, Daisuke Kurai, Koichi Murakami, Wataru Kamitani, et al. (+3)
122 [GO] 2020―Jun―10 Prevalence of comorbid asthma in COVID-19 patients Marcus W. Butler, Aoife O’Reilly, Eleanor M. Dunican, Patrick Mallon, Eoin R. Feeney, Michael P. Keane, Cormac McCarthy
123 [GO] 2020―Jun―10 Expression of SARS-CoV-2 Receptor ACE2 and Coincident Host Response Signature Varies by Asthma Inflammatory Phenotype Matthew J. Camiolo, Marc Gauthier, Naftali Kaminski, Anuradha Ray, Sally E. Wenzel
124 [GO] 2020―Jun―06 Association of asthma and its genetic predisposition with the risk of severe COVID-19 Zhaozhong Zhu, Kohei Hasegawa, Baoshan Ma, Michimasa Fujiogi, Carlos A. Camargo, Liming Liang
125 [GO] 2020―May―29 Successful use of methylprednisolone for treating severe COVID-19 Jing Liu, Xiaobin Zheng, Yiying Huang, Hong Shan, Jin Huang
126 [GO] 2020―May―29 SARS-CoV-2 Antibody Testing - Questions to be asked Mustafa K. Özçürümez, Andreas Ambrosch, Oliver Frey, Verena Haselmann, Stefan Holdenrieder, Michael Kiehntopf, et al. (+5)
127 [GO] 2020―May―28 The bimodal SARS-CoV-2 outbreak in Italy as an effect of environmental and allergic causes Salvatore Chirumbolo, Geir Bjørklund
128 [GO] 2020―May―26 Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial Yang Cao, Jia Wei, Liang Zou, Tiebin Jiang, Gaoxiang Wang, Liting Chen, et al. (+15)
129 [GO] 2020―May―26 Does asthma affect morbidity or severity of Covid-19? Kenji Matsumoto, Hirohisa Saito
130 [GO] 2020―May―22 ACE2, TMPRSS2 AND FURIN GENE EXPRESSION IN THE AIRWAYS OF PEOPLE WITH ASTHMA - IMPLICATIONS FOR COVID-19 Peter Bradding, Matthew Richardson, Timothy S.C. Hinks, Peter H. Howarth, David F. Choy, Joseph R. Arron, et al. (+2)
131 [GO] 2020―May―20 Clinical Testing For Covid-19 Stephanie Ward, Andrew Lindsley, Josh Courter, Amal Assa’ad
132 [GO] 2020―May―18 Elevated levels of interleukin-6 and CRP predict the need for mechanical ventilation in COVID-19 Tobias Herold, Vindi Jurinovic, Chiara Arnreich, Brian J. Lipworth, Johannes C. Hellmuth, Michael von Bergwelt-Baildon, et al. (+2)
133 [GO] 2020―May―16 Perforin and resistance to SARS coronavirus 2 Louise Cunningham, Peter Simmonds, Ian Kimber, David Arthur Basketter, John Paul McFadden
134 [GO] 2020―May―15 COVID-19 infection in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab Ulrike Förster-Ruhrmann, Agnieszka J. Szczepek, habil Claus Bachert, habil Heidi Olze
135 [GO] 2020―May―14 COMPLEMENT ACTIVATION IN PATIENTS WITH COVID-19: A NOVEL THERAPEUTIC TARGET Massimo Cugno, Pier Luigi Meroni, Roberta Gualtierotti, Samantha Griffini, Elena Grovetti, Adriana Torri, et al. (+5)
136 [GO] 2020―May―12 Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients - a perspective Lennart Hammarström, Hassan Abolhassani, Fausto Baldanti, Harold Marcotte, Qiang Pan-Hammarström
137 [GO] 2020―May―11 Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease Emanuele Pontali, Stefano Volpi, Giancarlo Antonucci, Marco Castellaneta, Davide Buzzi, Francesca Tricerri, et al. (+9)
138 [GO] 2020―May―11 Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China Ruchong Chen, Ling Sang, Mei Jiang, Zhaowei Yang, Nan Jia, Wanyi Fu, et al. (+29)
139 [GO] 2020―May―11 The immunologic status of newborns born to SARS-CoV2-infected mothers in Wuhan, China Pin Liu, Junwen Zheng, Pu Yang, Xia Wang, Cong Wei, Shiyu Zhang, et al. (+6)
140 [GO] 2020―May―08 COVID-19: unanswered questions on immune response and pathogenesis Enrico Maggi, Giorgio Walter Canonica, Lorenzo Moretta
141 [GO] 2020―May―07 Air pollution, racial disparities and COVID-19 mortality Eric B. Brandt, Andrew F. Beck, Tesfaye B. Mersha
142 [GO] 2020―May―01 Perspective: COVID-19, Implications of nasal diseases and consequences for their management Li Jian, Wei Yi, Nan Zhang, Wen Weiping, Olga Krysko, Woo-Jung Song, Claus Bachert
143 [GO] 2020―Apr―29 Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 Yang Yang, Chenguang Shen, Jinxiu Li, Jing Yuan, Jinli Wei, Fengmin Huang, et al. (+19)
144 [GO] 2020―Apr―29 Type I IFN immunoprofiling in COVID-19 patients Sophie Trouillet-Assant, Sebastien Viel, Alexandre Gaymard, Sylvie Pons, Jean-Christophe Richard, Magali Perret, et al. (+6)
145 [GO] 2020―Apr―27 COVID-19 diagnostic process in mainland China: the math beyond pneumonia Feng Wu, Weishan Huang
146 [GO] 2020―Apr―27 Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination Andrew W. Lindsley, Justin T. Schwartz, Marc E. Rothenberg
147 [GO] 2020―Apr―27 Will environmental impacts of social distancing due to the SARS-CoV-2 pandemic decrease allergic disease? Valentin Navel, Frédéric Chiambaretta, Frédéric Dutheil
148 [GO] 2020―Apr―22 A possible role for B cells in COVID-19?: Lesson from patients with Agammaglobulinemia Isabella Quinti, Vassilios Lougaris, Cinzia Milito, Francesco Cinetto, Antonio Pecoraro, Ivano Mezzaroma, et al. (+9)
149 [GO] 2020―Apr―22 Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2 Daniel J. Jackson, William W. Busse, Leonard B. Bacharier, Meyer Kattan, George T. O’Connor, Robert A. Wood, et al. (+10)
150 [GO] 2020―Apr―16 An academic allergy unit during COVID-19 pandemic in Italy Giacomo Malipiero, Giovanni Paoletti, Francesca Puggioni, Francesca Racca, Sebastian Ferri, Antonino Marsala, et al. (+5)
151 [GO] 2020―Apr―12 Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Xiaochen Li, Shuyun Xu, Muqing Yu, Ke Wang, Yu Tao, Ying Zhou, et al. (+12)
152 [GO] 2020―Mar―31 Running a virtual allergy division and training program in the time of COVID-19 pandemic Christopher D. Codispoti, Sindhura Bandi, James Moy, Mahboobeh Mahdavinia
153 [GO] 2019―Dec―04 The role of the changing human microbiome in the asthma pandemic Timothy C. Borbet, Xiaozhou Zhang, Anne Müller, Martin J. Blaser
154 [GO] 2019―Dec―04 The role of the changing human microbiome in the asthma pandemic


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.008 sec